134 related articles for article (PubMed ID: 35019261)
21. Renal-clearable zwitterionic conjugated hollow ultrasmall Fe
Liu W; Deng G; Wang D; Chen M; Zhou Z; Yang H; Yang S
J Mater Chem B; 2020 Apr; 8(15):3087-3091. PubMed ID: 32207500
[TBL] [Abstract][Full Text] [Related]
22. HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging.
Huang J; Xie J; Chen K; Bu L; Lee S; Cheng Z; Li X; Chen X
Chem Commun (Camb); 2010 Sep; 46(36):6684-6. PubMed ID: 20730157
[TBL] [Abstract][Full Text] [Related]
23. Development of PEGylated KMnF3 nanoparticles as a T1-weighted contrast agent: chemical synthesis, in vivo brain MR imaging, and accounting for high relaxivity.
Liu ZJ; Song XX; Tang Q
Nanoscale; 2013 Jun; 5(11):5073-9. PubMed ID: 23640287
[TBL] [Abstract][Full Text] [Related]
24. Structure-property relationships in manganese oxide--mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery.
Chen Y; Chen H; Zhang S; Chen F; Sun S; He Q; Ma M; Wang X; Wu H; Zhang L; Zhang L; Shi J
Biomaterials; 2012 Mar; 33(7):2388-98. PubMed ID: 22177841
[TBL] [Abstract][Full Text] [Related]
25. Ultrasmall MnSe Nanoparticles as
Chen SH; Huang LY; Huang B; Zhang M; Li H; Pang DW; Zhang ZL; Cui R
ACS Appl Mater Interfaces; 2022 Mar; 14(9):11167-11176. PubMed ID: 35226454
[TBL] [Abstract][Full Text] [Related]
26. Biocompatible Peptide-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles for In Vivo Contrast-Enhanced Magnetic Resonance Imaging.
Chee HL; Gan CRR; Ng M; Low L; Fernig DG; Bhakoo KK; Paramelle D
ACS Nano; 2018 Jul; 12(7):6480-6491. PubMed ID: 29979569
[TBL] [Abstract][Full Text] [Related]
27. Hybrids of manganese oxide and lipid liquid crystalline nanoparticles (LLCNPs@MnO) as potential magnetic resonance imaging (MRI) contrast agents.
Flak D; Zalewski T; Fiedorowicz K; Przysiecka Ł; Jarek M; Klimaszyk A; Kempka M; Zimna A; Rozwadowska N; Avaro J; Liebi M; Nowaczyk G
J Mater Chem B; 2023 Sep; 11(36):8732-8753. PubMed ID: 37655519
[TBL] [Abstract][Full Text] [Related]
28. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.
Na HB; Lee JH; An K; Park YI; Park M; Lee IS; Nam DH; Kim ST; Kim SH; Kim SW; Lim KH; Kim KS; Kim SO; Hyeon T
Angew Chem Int Ed Engl; 2007; 46(28):5397-401. PubMed ID: 17357103
[No Abstract] [Full Text] [Related]
29. Ultrasmall Ferrite Nanoparticles Synthesized via Dynamic Simultaneous Thermal Decomposition for High-Performance and Multifunctional T
Zhang H; Li L; Liu XL; Jiao J; Ng CT; Yi JB; Luo YE; Bay BH; Zhao LY; Peng ML; Gu N; Fan HM
ACS Nano; 2017 Apr; 11(4):3614-3631. PubMed ID: 28371584
[TBL] [Abstract][Full Text] [Related]
30. The use of silica coated MnO nanoparticles to control MRI relaxivity in response to specific physiological changes.
Lee YC; Chen DY; Dodd SJ; Bouraoud N; Koretsky AP; Krishnan KM
Biomaterials; 2012 May; 33(13):3560-7. PubMed ID: 22341582
[TBL] [Abstract][Full Text] [Related]
31. Rutin-coated ultrasmall manganese oxide nanoparticles for targeted magnetic resonance imaging and photothermal therapy of malignant tumors.
Fu S; Cai Z; Gu H; Lui S; Ai H; Song B; Wu M
J Colloid Interface Sci; 2024 Sep; 670():499-508. PubMed ID: 38776685
[TBL] [Abstract][Full Text] [Related]
32. FePt@MnO-Based Nanotheranostic Platform with Acidity-Triggered Dual-Ions Release for Enhanced MR Imaging-Guided Ferroptosis Chemodynamic Therapy.
Yang B; Liu Q; Yao X; Zhang D; Dai Z; Cui P; Zhang G; Zheng X; Yu D
ACS Appl Mater Interfaces; 2019 Oct; 11(42):38395-38404. PubMed ID: 31554396
[TBL] [Abstract][Full Text] [Related]
33. Cell uptake and intracellular fate of phospholipidic manganese-based nanoparticles.
Costanzo M; Scolaro L; Berlier G; Marengo A; Grecchi S; Zancanaro C; Malatesta M; Arpicco S
Int J Pharm; 2016 Jul; 508(1-2):83-91. PubMed ID: 27173822
[TBL] [Abstract][Full Text] [Related]
34. Dye-Anchored MnO Nanoparticles Targeting Tumor and Inducing Enhanced Phototherapy Effect via Mitochondria-Mediated Pathway.
Zhou L; Wu Y; Meng X; Li S; Zhang J; Gong P; Zhang P; Jiang T; Deng G; Li W; Sun Z; Cai L
Small; 2018 Sep; 14(36):e1801008. PubMed ID: 30095225
[TBL] [Abstract][Full Text] [Related]
35. A Bioinspired Nanoprobe with Multilevel Responsive T
Li Y; Zhao X; Liu X; Cheng K; Han X; Zhang Y; Min H; Liu G; Xu J; Shi J; Qin H; Fan H; Ren L; Nie G
Adv Mater; 2020 Jan; 32(4):e1906799. PubMed ID: 31799765
[TBL] [Abstract][Full Text] [Related]
36. Synthesizing and staining manganese oxide nanoparticles for cytotoxicity and cellular uptake investigation.
Omid H; Oghabian MA; Ahmadi R; Shahbazi N; Hosseini HR; Shanehsazzadeh S; Zangeneh RN
Biochim Biophys Acta; 2014 Jan; 1840(1):428-33. PubMed ID: 24112973
[TBL] [Abstract][Full Text] [Related]
37. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells.
Kim T; Momin E; Choi J; Yuan K; Zaidi H; Kim J; Park M; Lee N; McMahon MT; Quinones-Hinojosa A; Bulte JW; Hyeon T; Gilad AA
J Am Chem Soc; 2011 Mar; 133(9):2955-61. PubMed ID: 21314118
[TBL] [Abstract][Full Text] [Related]
38. Versatile Octapod-Shaped Hollow Porous Manganese(II) Oxide Nanoplatform for Real-Time Visualization of Cargo Delivery.
Wei R; Gong X; Lin H; Zhang K; Li A; Liu K; Shan H; Chen X; Gao J
Nano Lett; 2019 Aug; 19(8):5394-5402. PubMed ID: 31286778
[TBL] [Abstract][Full Text] [Related]
39. Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform.
Ha TL; Kim HJ; Shin J; Im GH; Lee JW; Heo H; Yang J; Kang CM; Choe YS; Lee JH; Lee IS
Chem Commun (Camb); 2011 Aug; 47(32):9176-8. PubMed ID: 21761053
[TBL] [Abstract][Full Text] [Related]
40. Fe(3)O(4)/MnO hybrid nanocrystals as a dual contrast agent for both T(1)- and T(2)-weighted liver MRI.
Im GH; Kim SM; Lee DG; Lee WJ; Lee JH; Lee IS
Biomaterials; 2013 Mar; 34(8):2069-76. PubMed ID: 23246062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
